beta-Lactamase Inhibitors

Known as: Antagonists, beta Lactamase, beta Lactamase Inhibitors, Inhibitors, beta Lactamase 
Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Carbapenem-resistant Enterobacteriaceae are amongst the most feared pathogens due to severely limited treatment options. In… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
This study sought to monitor the presence of carbapenem-resistant Enterobacteriaceae (CRE) and the proportion New Delhi metallo… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
Urinary tract infection is major health problem in Nepal. Considering, the majority of infection cases caused by… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2013
2013
OBJECTIVES To test the hypothesis that a multifaceted, local public campaign could be feasible and influence antibiotic… (More)
Is this relevant?
2013
2013
Background & objective: AmpC β-lactamases are clinically significant because they may confer resistance to a wide variety of… (More)
Is this relevant?
2011
2011
In order to analyze the presence of metallo-ß-lactamase in our country, we included in this study Pseudomonas aeruginosa isolates… (More)
Is this relevant?
2002
2002
Known carbapenem compounds with inhibitory effect towards beta-lactamase enzymes are formed from bicyclical beta lactam… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Small, soluble single-domain fragments derived from the unique variable region of dromedary heavy-chain antibodies (VHHs) against… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?